1. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA;
2. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Abuja, Nigeria;
3. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Kampala, Uganda;
4. National Cervical Cancer Control Program, Ministry of Health, Maputo, Mozambique;
5. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Maputo, Mozambique;
6. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana;
7. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Lusaka, Zambia;
8. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Lilongwe, Malawi;
9. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Dar es Salaam, Tanzania;
10. Ministry of Health and Social Services, Windhoek, Namibia;
11. Makerere University School of Public Health, Kampala, Uganda;
12. Division of National Cancer Control Program, Ministry of Health, Nairobi, Kenya;
13. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Harare, Zimbabwe;
14. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Mbabane, Eswatini;
15. Office of the Director of Public Health, Ministry of Health, Kampala, Uganda;
16. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Addis Ababa, Ethiopia; and
17. Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention (CDC), Windhoek, Namibia.